Use of Long-Acting Injectables in Borderline Personality Disorder: What Do We Know?

被引：0
|
作者：
Almeida, E. D. S. [1 ]
Abreu, J. [1 ]
Vaz, R. P. [1 ]
Martins, J. [1 ]
Cunha, F. [1 ]
Santos, I. [1 ]
Castro, N. [1 ]
Andrade, R. P. [1 ]
Monteiro, E. [1 ]
机构：
[1] Ctr Hosp Tondela Viseu, Viseu, Portugal
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0048
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [31] Inspirational chemistry of bioabsorbable long-acting injectables
    Thomas Tice
    Drug Delivery and Translational Research, 2023, 13 : 371 - 377
  • [32] Psychotherapeutic interventions for cannabis use disorder. What do we know and what should we do?
    Pouliquen, M.
    Auriacombe, M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2022, 48 (01): : 70 - 77
  • [33] Long-acting injectable risperidone in treatment resistant borderline personality disorder.: A small series report
    Diaz-Marsa, M.
    Galian, M.
    Montes, A.
    Fernandez, R.
    Arza, R.
    Lopez-Ibor, J. J.
    Carrasco, J. L.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2008, 36 (02): : 70 - 74
  • [34] Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group
    Andrea Bauer
    Philippe Berben
    Sudhir S. Chakravarthi
    Sayantan Chattorraj
    Ashish Garg
    Betty Gourdon
    Tycho Heimbach
    Ye Huang
    Christopher Morrison
    Deepak Mundhra
    Ramesh Palaparthy
    Pratik Saha
    Maxime Siemons
    Naveed A. Shaik
    Yi Shi
    Sara Shum
    Naveen K. Thakral
    Shweta Urva
    Ryan Vargo
    Venkat R. Koganti
    Stephanie E. Barrett
    Pharmaceutical Research, 2023, 40 : 1601 - 1631
  • [35] Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group
    Bauer, Andrea
    Berben, Philippe
    Chakravarthi, Sudhir S.
    Chattorraj, Sayantan
    Garg, Ashish
    Gourdon, Betty
    Heimbach, Tycho
    Huang, Ye
    Morrison, Christopher
    Mundhra, Deepak
    Palaparthy, Ramesh
    Saha, Pratik
    Siemons, Maxime
    Shaik, Naveed A.
    Shi, Yi
    Shum, Sara
    Thakral, Naveen K.
    Urva, Shweta
    Vargo, Ryan
    Koganti, Venkat R.
    Barrett, Stephanie E.
    PHARMACEUTICAL RESEARCH, 2023, 40 (07) : 1601 - 1631
  • [36] Utilizing long-acting injectables to address noncompliance among adolescents diagnosed with bipolar disorder
    Sood, Kanuja
    Buddhavarapu, Mahiya
    Bansal, Lajpat Rai
    Schaefer, Daniel
    Parikh, Parinda
    BIPOLAR DISORDERS, 2024, 26 (08) : 831 - 834
  • [37] Long-Acting Injectables: Current Perspectives and Future Promise
    Chaudhary, Komal
    Patel, Mayur M.
    Mehta, Priti J.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2019, 36 (02): : 137 - 181
  • [38] Leveraging Model Master Files for Long-Acting Injectables
    Gong, Yuqing
    Hopefl, Robert
    Li, Tonglei
    Hooker, Andrew C.
    Silva, Daniela Amaral
    Alam, Khondoker
    Ducharme, Murray
    Moody, Rebecca
    Saha, Pratik
    Babiskin, Andrew
    PHARMACEUTICAL RESEARCH, 2025,
  • [39] Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know?
    Connery, Hilary S.
    Weiss, Roger D.
    AMERICAN JOURNAL OF PSYCHIATRY, 2020, 177 (02): : 104 - 106
  • [40] Neurobiology of problematic pornography use: What we know, and what we do not know
    Brand, Matthias
    Potenza, Marc N.
    JOURNAL OF BEHAVIORAL ADDICTIONS, 2022, 11 : 166 - 166
12345